Targeted elimination of senescent cells by engineered extracellular vesicles attenuates atherosclerosis in ApoE<sup>-/-</sup> mice with minimal side effects.
Journal Information
Full Title: Theranostics
Abbreviation: Theranostics
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Diagnostic Imaging
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Competing Interests: Y. L., Z. L., W. C., B. T., L. Z., S. W., L. J., W. L., and Z. B. have a patent pending for this technology. The authors have declared that no competing interest exists."
"This work was funded by the National Natural Science Foundation of China (82272010) and the Key R&D Project in Shaanxi Province (2023-ZDLSF-22) to L. Yuan and the R&D Program of Beijing Municipal Education Commission (KM202010025013) and BJNSF7222078 to H. Xing."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025